Clinical and epidemiological characteristics of cancer cases reported between 2013-2017 in Amasya

Year 2023, , 113 - 126, 15.04.2023

Berkhan Topaktaş , Betül Karakuş , Neşe Yakşi

https://doi.org/10.20518/tjph.1164816

Abstract

Objective: In order to determine the region-specific risk factors of cancers, it is necessary to examine the distribution according to the characteristics of person, place and time. In the current study, it was aimed to determine the distribution of cancer diagnoses reported between 2013 and 2017 in Amasya province and these diagnoses in terms of clinical features and various sociodemographic variables.

Methods: The population of this descriptive study was composed of the cases who were diagnosed with cancer, which the Middle East Cancer Consortium deems necessary to be reported, in various health institutions between 2013 and 2017 and were registered in the Cancer Registry Center. The codes in ICD-O-3 were used in the classification of cancer diagnoses. In order to eliminate the confounding effect of the age variable in the presentation of cancer rates, age-standardized rates were calculated using the World Standard Population.

Results: The three most common cancers between 2013 and 2017 were trachea/bronchus/ lung, colorectal and stomach cancers. The three most common cancers in men were trachea/ bronchus/lung, prostate and stomach cancers. This was ranked as breast, colorectal and thyroid cancers in women. It was found that between 2013 and 2017, age-standardized rates of all cancers were found to increase from 151.3 to 184.1 per 100,000 population.

Conclusion: The incidence rate of all cancers for both genders between 2013 and 2017 is below Turkey’s average. Gastrointestinal system malignancies, especially gastric cancer, have an incidence rate higher compared to Turkey for both genders. Intervention studies should be planned using the results of the current study.

Keywords

Cancer, incidence, epidemiological studies

Supporting Institution

The present study was not funded by any person or institutions.

Amasya ilinde 2013-2017 yılları arasında bildirimi yapılan kanser olgularının klinik ve epidemiyolojik özellikleri

Abstract

Amaç: Kanserlerin bölgeye özgü risk faktörlerini belirlemek için dağılımını kişi, yer ve zaman özelliklerine göre incelemek gerekmektedir. Bu çalışmada Amasya ilinde 2013-2017 yılları arasında bildirimi yapılan kanser tanılarının dağılımının ve bu tanıların klinik özellikler ve çeşitli sosyodemografik değişkenler yönünden incelenmesi amaçlanmıştır.

Yöntem: Tanımlayıcı tipte planlanan bu çalışmanın evrenini 2013-2017 yılları arasında çeşitli sağlık kurumlarında kanser tanısı konularak Kanser Kayıt Merkezi’nde kayıt altına alınmış Orta Doğu Kanser Konsorsiyumu’nun rapor edilmesini gerekli gördüğü olgular oluşturdu. Kanser tanılarının sınıflandırılmasında ICD-O-3’te yer alan kodlar kullanıldı. Kanser hızlarının sunumunda yaş değişkeninin karıştırıcı etkisini ortadan kaldırmak için Dünya Standart Nüfusu kullanılarak yaşa standardize hızlar hesaplandı.

Bulgular: 2013-2017 yılları arasında en fazla görülen ilk üç kanser trakea/bronş/akciğer, kolorektal ve mide kanseri olarak belirlendi. Erkeklerde en sık görülen ilk üç kanser trakea/ bronş/akciğer, prostat ve mide kanseri; kadınlarda ise meme, kolorektal ve tiroid kanseri sıralamasına sahipti. 2013-2017 yılları arasında, tüm kanserlerin yaşa göre standardize edilmiş hızlarının yüz bin nüfusta 151.3’ten 184.1’e yükseldiği bulundu.

Sonuç: Her iki cinsiyet için tüm kanserlerin insidans hızı Türkiye genelinin altındadır. Gastrointestinal sistem maligniteleri özellikle de mide kanseri her iki cinsiyette Türkiye verilerinin üstünde bir insidans hızına sahiptir. Mevcut çalışmanın bulgularından faydalanarak müdahale çalışmaları planlanmalıdır.

Keywords

Kanser, insidans, epidemiyolojik çalışmalar

References

• Ferlay J, Colombet M, Soerjomataram I, et al. Cancer statistics for the year 2020: An overview. Int. J. Cancer 2021; 149(4):778-89.
• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca Cancer J Clin 2021; 71(3): 209-49.
• Cao B, Soerjomataram I, Bray F. The burden and prevention of premature deaths from noncommunicable diseases, including cancer: A global perspective. In: Wild CP, Weiderpass E, Stewart BW, editors. World cancer report cancer research for cancer prevention. Lyon, France: International Agency for Research on Cancer; 2020. p.16-23.
• Soerjomataram I, Bray F. Planning for tomorrow: Global cancer incidence and the role of prevention 2020–2070. Nat. Rev. Clin. Oncol 2021; 18(10):663-72.
• Young JL, Ward KC. Kanser kayıtçılığında standartlar için el kitabı. Çeviri Ed: Eser S, Ozalan S. Ankara; 2013.
• TÜİK (Turkish Statistical Institute). Population and Demography. Available at:https://data.tuik.gov.tr/Kategori/GetKategori?p=nufus-ve-demografi 109&dil=1. Accessed: Feb 10, 2022
• Fritz A, Percy C, Jack A, et al. International classification of diseases for oncology (ICD-O)–3rd edition, 1st revision. World Health Organization 2013.
• IARC. Cancer Fact Sheets 2020 . Available at:https://gco.iarc.fr/today/fact-sheets cancers. Accessed: Feb 11, 2022
• Kara F, Keskinkılıç B. Türkiye kanser istatistikleri. TR Ministry of Health General Directorate of Public Health, Ankara. 2017;19-44.
• Keskinkılıç B, Gültekin M, Karaca AS et al. Türkiye Kanser Kontrol Programı. TR Ministry of Health Turkish Public Health Institution Cancer Department, Ankara. 2016; 18-28.
• Amasya Provincial Health Directorate. Cancer Statistics Report, Amasya. 2018.
• Tuğba Özdemir Z, Akyüz Özkan E. Cancer Map of The Yozgat City. Bozok Medical Journal 2016;6(1):27-33.
• Yanik S, Yilmaz F, Özdemir ZT, et al. The analysis of 8-year data (2002-2010) of the tumor cases based on the pathology records of Abant Izzet Baysal University medical faculty department. Int. J. Clin. Exp. 2014;7(8):2273.
• Kuzey MA. Düzce Tıp Fakültesi Hastanesi Patoloji arşivindeki 10 yılık (1999-2008) kanser olgularının genel değerlendirmesi (Epidemiyolojik bir çalışma). [Thesis in medicine]. 2009.
• İzmirli M, Altin S, Dernek B, Ünsal M. SSK Okmeydani Education and Research Hospital, Centre of Oncology in 1999-2004 cancer statistics. Turk J Oncol. 2007;22(4):172-82.
• Haydaroğlu A, Fatma S, Caner A. Epidemiological and overall survival characteristics of cancer patients in Ege University Hospital database. Ege Journal of Medicine 2019:1-9.
• Yücel B, Akkaş EA, Okur Y, Tezer ES, Kılıçkap S. Demographic distribution and survival data of patients with cancer admitted to Department of Oncology, Cumhuriyet University Medical Faculty Cumhuriyet Medical Journal 2014;36(2):184-96.
• Aguilar I, Compés L, Feja C, Rabanaque M, Martos C. Gastric cancer incidence and geographical variations: The influence of gender and rural and socioeconomic factors, Zaragoza (Spain). Gastric Cancer 2013;16(2):245-53.
• Engin H, Ozdamar S, Gun B, et al. Epidemiological data of cancer of the only cancer center of the western Black Sea region of Turkey. Journal of Clinical Oncology 2006;24(18_suppl):16041-16041.
• Correa P. The epidemiology of gastric cancer. World journal of surgery 1991;15(2):228-34.
• Fukase K, Kato M, Kikuchi S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. The Lancet 2008;372(9636):392-7.
• Korkmaz M, Sadıç M, Koca G, et al. The relationship of Helicobacter pylori infection with demographic, socioeconomic and environmental factors: Ankara Hospital experience. Kafkas Med Sci 2013;(2):74-9.
• Yıldırım T, Dursun M. Analysis of Helicobacter pylori positiveness and upper gastrointestinal system endoscopy results of Yozgat region in Turkey. J Health Sci Med 2021;4(6):901-6.
• Ozaydın N, Turkyilmaz SA, Cali S. Prevalence and risk factors of helicobacter pylori in Turkey: a nationally-representative, cross-sectional, screening with the 13 C-Urea breath test. BMC Public Health 2013;13(1):1-12.